PKO Investment Management Joint-Stock’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
BHIA
NONA
SIM
AAIS
PKO Investment Management Joint-Stock's EW Position: Q2 2026 in Review
PKO Investment Management Joint-Stock increased its Edwards Lifesciences (EW) stake by 13% in Q2 2026, buying an estimated $58.6K and bringing the position to 6,000 shares worth $543K. The position accounts for 0.04% of the portfolio, ranked #195.
PKO Investment Management Joint-Stock first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.39M in Q3 2023. 458 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- PKO Investment Management Joint-Stock held 6,000 shares of Edwards Lifesciences worth $543K as of Q2 2026.
- PKO Investment Management Joint-Stock bought 700 Edwards Lifesciences shares in Q2 2026, an estimated $58.6K.
- Edwards Lifesciences made up 0.04% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #195 holding.
- PKO Investment Management Joint-Stock first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
- PKO Investment Management Joint-Stock's Edwards Lifesciences position peaked at $1.39M in Q3 2023.
- 458 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.